Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Long-Term Debt Repayments (2016 - 2018)

Apyx Medical filings provide 8 years of Long-Term Debt Repayments readings, the most recent being $5.4 million for Q4 2018.

  • On a quarterly basis, Long-Term Debt Repayments rose 1189.0% to $5.4 million in Q4 2018 year-over-year; TTM through Sep 2019 was $5.4 million, a 336.73% increase, with the full-year FY2023 number at $11.0 million, changed N/A from a year prior.
  • Long-Term Debt Repayments hit $5.4 million in Q4 2018 for Apyx Medical, up from -$2.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $6.6 million in Q4 2014 to a low of -$3.6 million in Q1 2014.
  • Median Long-Term Debt Repayments over the past 5 years was -$59000.0 (2016), compared with a mean of $281350.0.
  • The widest YoY moves for Long-Term Debt Repayments: up 11162.71% in 2014, down 10664.71% in 2014.
  • Apyx Medical's Long-Term Debt Repayments stood at $6.6 million in 2014, then crashed by 106.31% to -$419000.0 in 2015, then soared by 85.68% to -$60000.0 in 2016, then surged by 796.67% to $418000.0 in 2017, then soared by 1189.0% to $5.4 million in 2018.
  • The last three reported values for Long-Term Debt Repayments were $5.4 million (Q4 2018), -$2.8 million (Q3 2018), and $180000.0 (Q2 2018) per Business Quant data.